Fulgent Genetics, Inc.
FLGT
$18.82
-$0.74-3.78%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -3.61% | 6.23% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -3.61% | 6.23% | |||
| Cost of Revenue | 1.70% | -1.35% | |||
| Gross Profit | -11.00% | 18.97% | |||
| SG&A Expenses | -0.36% | 12.65% | |||
| Depreciation & Amortization | -0.10% | -0.05% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.98% | 3.97% | |||
| Operating Income | -22.68% | 5.53% | |||
| Income Before Tax | -45.72% | 56.59% | |||
| Income Tax Expenses | 109.49% | 51.67% | |||
| Earnings from Continuing Operations | -92.23% | 57.87% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 22.19% | 556.52% | |||
| Net Income | -95.82% | 59.80% | |||
| EBIT | -22.68% | 5.53% | |||
| EBITDA | -39.56% | 10.90% | |||
| EPS Basic | -94.69% | 60.11% | |||
| Normalized Basic EPS | -46.37% | 10.50% | |||
| EPS Diluted | -93.78% | 59.93% | |||
| Normalized Diluted EPS | -46.37% | 10.50% | |||
| Average Basic Shares Outstanding | 0.59% | 0.78% | |||
| Average Diluted Shares Outstanding | 0.59% | 0.78% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||